• Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

    Источник: Nasdaq GlobeNewswire / 15 авг 2023 06:05:00   America/Chicago

    N/A
Опубликовать